Bio-Thera Solutions, Ltd., established in 2003, adheres to the philosophy of "Innovation for Life" and is committed to an innovation-driven development strategy.The company focuses on developing next-generation antibody drugs for the treatment of cancer, autoimmune diseases, cardiovascular diseases, and other major diseases that threaten human life or health. As a leader in the research and development of next-generation antibody drugs, Bio-Thera has successfully obtained several domestic and international patents in target development, antibody engineering, therapeutic method development, and antibody production, with many more patents submitted or under review.
* Project represents differentiated antibodies
